Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Schiller
GLOBETECH PUBLISHING LLC

Approval of Expansion of Cardioverter Defibrillator Trial to Include MRI Full-Body Scans

By Medimaging International staff writers
Posted on 03 Jun 2014
A new magnetic resonance imaging (MRI)-compatible, implantable cardioverter defibrillators (ICDs) provide physicians with the complete diagnostic capabilities of a dual-chamber ICD, including atrial sensing and sophisticated shock reduction algorithms with only one lead.

Biotronik (Berlin, Germany), a manufacturer of cardiovascular medical devices, reported that the US Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI trial. The approval will allow patients enrolled in phase C of the trial to receive full-body scans, and for the first time, include patients with DX ICDs in the study.

Biotronik, in 2011, received CE marking of approval and became the first company worldwide with an ICD approved for use in a MRI scanner. The ProMRI study is the next step in making this technology widely available in the United States. Biotronik introduced DX technology in 2013 in the United States, and it has been rapidly accepted by US electrophysiologists. Patients prefer implants with less hardware while physicians benefit from dual-chamber diagnostic data.

“With the DX system, I gain important diagnostic and therapeutic information. For my primary prevention patients with no dual chamber pacing indication, the implant procedures are straightforward, and it makes sense to use as little hardware as possible,” said Harpreet S. Grewal, MD, FACC, FHRS, from Richmond Cardiology Associates (Richmond, VA, USA). “The potential to provide this therapy and have it approved for use in full-body MRI conditions adds clinical value.”

Phase C of the ProMRI trial is the final phase in a series of MRI compatibility trials conducted by Biotronik in rapid succession. Phase A and phase B of the trial evaluated the safety of Biotronik Entovis pacemaker systems during MRI scans. Phase A resulted in FDA approval on May 6, 2014, of Entovis systems for MRI scans with an exclusion zone. Phase B expanded the trial to evaluate the safety of Entovis pacemaker systems for full-body scans, including cardiac and thoracic spinal scans. Phase B is nearing completion and data will soon be submitted to FDA.

“We are anxiously awaiting the day when this important diagnostic capability, up to now only available to pacemaker patients, can also benefit ICD patients,” said Kevin Mitchell, vice president, clinical studies at Biotronik, Inc. “Biotronik is committed to extending its ProMRI technology to as many patients as possible. We were the first company to offer ICD patients in the United States MRI access, and remain the only company that provides single-chamber pacemaker patients access to this diagnostic tool.”

Every year, about 200,000 patients in the United States are implanted with ICDs, and studies estimate that 50%–75% of them will develop a clinical need for an MRI scan during their lifetime. MRI scans frequently provide improved diagnostic capabilities for specific that cannot be adequately examined by X-ray, computed tomography (CT), or ultrasound. The strong forces applied during an MRI scan can have a negative effect on both device and patient, and are usually contraindicated for pacemaker and ICD patients.

With its ProMRI technology, Biotronik has developed a solution to enable all cardiac rhythm patients’ access to MRI scanning. ProMRI technology is already used widely in Europe, including recent CE approval for MR-Conditional full-body and 3.0 Tesla scans with the Ilesto/Iforia ICD system. The Biotronik -sponsored trial has been in US subject recruitment since March 2013.

Related Links:

Biotronik



Channels

Radiography

view channel

New Patient-Centered Tool Devised to Record Side Effects of Radiotherapy

Researchers have investigated a patient-centered approach to evaluating the side effects of radiotherapy and have shown that it may be able to optimize the detection and management of treatment-related toxicity. For lung tumors that cannot be removed with surgery, radiotherapy is the best treatment option.... Read more

Ultrasound

view channel

Guidelines Released for Quantitative Monitoring of Critically Ill and Surgery Patients Using Echocardiography

The American Society of Echocardiography (ASE; Morrisville, NC, USA) has published clinical guidelines describing how and when echocardiography can be used for medical and surgical therapy in adult patients. The guidelines were published in the January 2015 issue of the American Society of Echocardiography.... Read more

Nuclear medicine

view channel
Image: Created by averaging PET scan data from chronic pain patients (left) and healthy controls (right), the images reveal higher levels of inflammation-associated translocator protein (orange/red) in the thalamus and other brain regions of chronic pain patients (Photo courtesy of Marco Loggia, Martinos Center for Biomedical Imaging, Massachusetts General Hospital).

PET/MR Imaging Shows First Evidence of Neuroinflammation in Chronic Pain Patients’ Brains

For the first time, researchers have used neuroimaging strategies to find evidence of neuroinflammation in major regions of the brains of patients with chronic pain. By showing that levels of an i... Read more

General/Advanced Imaging

view channel
Image: Dr. Miles was part of the team that helped identify facial measurements in children with autism that may lead to a screening tool for young children and provide clues to its genetic causes (Photo courtesy of Rebecca F. Miller).

Advanced 3D Facial Imaging Designed to Help in Early Identification of Autism

Autism is a range of closely related disorders observed in patients who exhibit a shared assortment of symptoms, including delays in learning to communicate and interrelate socially. Early detection of... Read more

Imaging IT

view channel

Potential Cost of Data Breaches of Protected Health Information Could Reach USD 5.6 Billion Annually

The healthcare industry and institutions face an ever-increasing threat of data breaches to clinical and patient information. Cybercriminals are attracted to Protected Health Information (PHI) such as Social Security Numbers (SSN) on Medicare cards, and other sensitive medical information stored online on an institutions'... Read more

Industry News

view channel

New Strategic Partnership Agreement for Surgical Displays

An agreement between Barco (Kortrijk, Belgium), a visualization products company, and Medical Computers Deutschland (MCD; Moenchengladbach, Germany), a supplier of customized Healthcare IT (Information Technology) solutions, covers the sale of surgical displays for the healthcare industry in Germany, Austria, and Switzerland.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.